Philips Respironics Recall Information

Click here to learn more about the Philips Respironics Device Recall & Mask Contraindication Update.

Skip to Content
Close Icon

JSM Forum 2020 Videos

Home Our Partners JSM Forum 2020 JSM Forum Video Library

Video Presentations

 

Diagnosis, Clinical Implications and Treatment Options Associated with OSA

Srinivasan Devanathan, MD, Medical Director of Adult Sleep Medicine and Pulmonary, Sleep & Internal Medicine Physician at Parkview Hospital

Dr. Devanathan reviews OSA/CSA, along with the key features, implications and comorbidities associated with SDB/OSA/CSA, as well as review current treatment options.

  • Review disease state and why OSA can be hard to diagnose
  • Reasons to know pathogenesis and spectrum of SDB and OSA
  • Implications of OSA relative to co-morbidities and public health and safety

Care of Patients with Neuromuscular Diseases

Nader Mina, MD, Medical Director of Sleep Evaluation Services and Pulmonary, Sleep & Critical Care Physician at Beaumont Health, Director for Southfield Sleep Operations and Assistant Professor at Oakland University William Beaumont School of Medicine

Dr. Mina reviews aspects of respiratory and sleep support for patients with chronic neuromuscular respiratory failure including the use of NIV, cough assist and clearance devices.

  • Understand the basics of Sleep Apnea
  • Current therapies for Sleep Apnea
  • Future therapies for Sleep Apnea

Residual Sleepiness After PAP Treatment of OSA

Navin Jain, MD, FCCP, FAASM, Pulmonary, Critical Care, Internal Medicine and Sleep Medicine Physician at the Toledo Clinic

Dr. Jain discusses evaluation of residual sleepiness, including history, PAP download, PSG, re-study, wakefulness promoting agents, and more.

  • Understand etiology of residual sleepiness after PAP treatment
  • Review and discuss differential diagnosis
  • How to successfully treat residual sleepiness

Growth of Healthcare Outside the Hospital, Powered by Digital Health

Mick Farrell, BE, SM, MBA; CEO at ResMed

Mick Farrell discusses the growth of healthcare delivery in out-of-hospital environments including HME, SNF, home health, hospice, and life plan communities. Mick also looks at digital health technologies and their impact on healthcare delivery, with a particular focus on sleep apnea, COPD, and asthma.

  • Overview of healthcare delivery in out-of-hospital environments
  • Logical arguments as to why healthcare systems and payers as well as individuals are driving this trend
  • Impact of COVID-19 as a catalyst in this context
  • Case study in the end-to-end digitization of a patient pathway for sleep apnea
  • Applications of digital health in COPD and asthma

The Rise of School Shootings: Could Sleep Play a Role?

Amber Allen, RPSGT, RST, CCSH, Director of the Polysomnographic Technology Program at Collin College and Director and Chair of Education and CSTE Committee on the BRPT Board of Directors

Amber Allen provides a look at teenage brain development, the effects of sleep deprivation on the teenage brain, and how this may play into why school shootings are on the rise when teen sleep is on the decline.

  • Examine school shooting statistics and the mindsets of school shooters, with a focus on the sleep behavior of the Columbine school shooters
  • Discuss the development of the teenage brain and how sleep deprivation and rising technology use affects it
  • Examine why sleep deprivation is under-recognized in the adolescent population and why it may be a contributing factor to school shootings

Behavioral Treatments for Insomnia

Donna Arand, PhD, DABSM, FAASM, Associate Research Professor at Wright State University Boonshoft School of Medicine and former President of the Society of Behavioral Sleep Medicine

Dr. Arand reviews the prevalence and cost of insomnia, behavioral treatments for insomnia and effectiveness in diverse populations. She also examines the effectiveness and limitations of digital cognitive behavioral therapy for insomnia.

  • Discuss the various behavioral treatments for insomnia
  • Describe the components of cognitive behavioral therapy for insomnia (CBT-I)
  • Compare and contrast different delivery methods for CBT-I

Treating OSA: Mechanisms of Current Therapy

Kingman P. Strohl, MD, Professor of Medicine, Physiology & Biophysics, and Oncology at Case Western Reserve University, & Director at the Center for Sleep Disorders Research at the Louis Stokes VA Medical Center

Dr. Strohl discusses the anatomy associated with OSA along with physiologic causes for recurrent sleep apnea. This lecture reviews relevance of anatomy to OSA treatment while also reviewing targets of OSA therapy.

  • Compare risk factors to physiologic causes for recurrent sleep apnea
  • Recount the importance of anatomy in OSA treatment
  • List other targets for therapy

Bronchiectasis and Airway Clearance - Underdiagnosed and Undertreated

Joseph Khabbaza, MD, Pulmonary & Critical Care Physician at the Cleveland Clinic Respiratory Institute

Dr. Khabbaza provides a general overview of the epidemiology and physiology of bronchiectasis. He also discusses the treatment of underlying causes and the importance of airway clearance.

  • Identify what bronchiectasis is and how it is diagnosed
  • Understand the different causes of bronchiectasis
  • Understand the importance of airway clearance in the successful treatment of bronchiectasis

Ethical Issues and Decision Making in Respiratory Care

Edward Warren, MD, Director of Pulmonary and Critical Care Medicine at MetroHealth Medical Center

Dr. Warren reviews the ethical considerations and potential conflicts in the delivery of respiratory care. He discusses how the care of patients with COVID-19 has been brought to the forefront in ethical considerations for Respiratory Therapists.

  • Understand the potential ethical issues in respiratory care
  • Know your responsibilities and rights in regards to providing care
  • Know the particular ethical issues around the care of COVID and other respiratory pandemics

COVID-19 Pandemic in the Clinical Environment: Implications for Long-term and Short-term Oxygen Therapy

Keith Robinson, MD, MS, FCCP, Senior Medical Director at Syneos Health

According to the World Health Organization, 15 percent of COVID-19 patients will require oxygen therapy as part of their treatment and recovery from the virus. Dr. Robinson explores the path of the virus, the current situation in healthcare, discharge planning with oxygen therapy, and the road ahead.

  • Understand the pathophysiology of COVID-19 SARS-CoV-2 infection and its four phases of illness
  • Navigate patient discharge planning and prescribing oxygen therapy during a pandemic. What does the discharge patient look like at recovery?
  • Review the impact on patients with chronic illness. What are leading lung-health and research nonprofit organizations saying about the long term effects on individuals and the road ahead?

These lectures were presented live during the 2020 Jean S. Marx Memorial Education Forum virtual event on Wednesday, November 18th, 2020. CEU credit cannot be obtained from watching these videos.